GANGLIOSIDOSIS

Clinical trials for GANGLIOSIDOSIS explained in plain language.

Never miss a new study

Get alerted when new GANGLIOSIDOSIS trials appear

Sign up with your email to follow new studies for GANGLIOSIDOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

One-Time IV treatment aims to halt fatal childhood brain disease

Disease control Recruiting now

This study is testing a one-time intravenous (IV) gene therapy for children with GM1 gangliosidosis, a rare and fatal genetic disorder that destroys nerve cells. The therapy aims to deliver a working copy of a missing gene so the body can produce a vital enzyme, potentially slowi…

Matched conditions: GANGLIOSIDOSIS

Phase: PHASE1, PHASE2 • Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Disease control

Last updated Mar 31, 2026 12:12 UTC

GANGLIOSIDOSIS

Get alerted when new GANGLIOSIDOSIS trials appear

One-Time IV treatment aims to halt fatal childhood brain disease